Daxor Corp (DXR)
9.94
+0.20
(+2.05%)
USD |
NASDAQ |
Apr 19, 13:04
Daxor SG&A Expense (Quarterly)
SG&A Expense (Quarterly) Chart
Historical SG&A Expense (Quarterly) Data
Date | Value |
---|---|
December 31, 2011 | 2.711M |
September 30, 2011 | 7.191M |
June 30, 2011 | 0.483M |
March 31, 2011 | 2.568M |
December 31, 2010 | -3.156M |
September 30, 2010 | -4.157M |
June 30, 2010 | 0.0456M |
March 31, 2010 | -0.2934M |
December 31, 2009 | 12.48M |
September 30, 2009 | -2.510M |
June 30, 2009 | -6.506M |
March 31, 2009 | 1.626M |
December 31, 2008 | -1.695M |
September 30, 2008 | -8.508M |
June 30, 2008 | -1.538M |
March 31, 2008 | -7.082M |
December 31, 2007 | -15.85M |
September 30, 2007 | 1.695M |
June 30, 2007 | 1.632M |
March 31, 2007 | -2.783M |
December 31, 2006 | -3.481M |
September 30, 2006 | 1.517M |
June 30, 2006 | 1.703M |
March 31, 2006 | -0.0411M |
December 31, 2005 | -0.1496M |
Date | Value |
---|---|
September 30, 2005 | -0.7303M |
June 30, 2005 | 1.351M |
March 31, 2005 | 0.3321M |
December 31, 2004 | 0.1056M |
September 30, 2004 | 0.0037M |
June 30, 2004 | 0.1678M |
March 31, 2004 | -0.0121M |
December 31, 2003 | -1.454M |
September 30, 2003 | 0.5966M |
June 30, 2003 | 0.6565M |
March 31, 2003 | 0.6534M |
December 31, 2002 | -1.262M |
September 30, 2002 | 0.5103M |
June 30, 2002 | 0.4686M |
March 31, 2002 | 0.4108M |
December 31, 2001 | -1.560M |
September 30, 2001 | 0.3446M |
June 30, 2001 | 0.3374M |
March 31, 2001 | 0.3676M |
December 31, 2000 | 0.0517M |
September 30, 2000 | -0.2785M |
June 30, 2000 | -0.1586M |
March 31, 2000 | -0.111M |
December 31, 1999 | 0.4903M |
September 30, 1999 | -0.10M |
SG&A Expense Definition
SG&A expense (short for Selling, General and Administrative expense) is a line item on the income statement, though sometimes sales and marketing expenses are reported separately from general and administrative expenses.
SG&A Expense (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
SG&A Expense (Quarterly) Benchmarks
AptarGroup Inc | 138.30M |
Sanara MedTech Inc | 16.34M |
Precision Optics Corp Inc | 1.933M |
Warby Parker Inc | 108.64M |
Perspective Therapeutics Inc | 1.694M |